Hepion Pharmaceuticals, Inc.
HEPA
$0.2975
$0.01294.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.79% | 24.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -73.03% | -47.57% | |||
| Operating Income | 73.03% | 47.57% | |||
| Income Before Tax | 68.20% | -23.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 68.20% | -23.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 68.20% | -23.97% | |||
| EBIT | 73.03% | 47.57% | |||
| EBITDA | 73.03% | 47.57% | |||
| EPS Basic | 69.33% | -7.00% | |||
| Normalized Basic EPS | 48.78% | 49.64% | |||
| EPS Diluted | 69.33% | -7.00% | |||
| Normalized Diluted EPS | 48.78% | 49.64% | |||
| Average Basic Shares Outstanding | 3.65% | 15.86% | |||
| Average Diluted Shares Outstanding | 3.65% | 15.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||